{
    "code": "02023512",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02023512",
    "time": "2021-01-29 04:55:32",
    "許可證字號": "衛署藥輸字第023512號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "111\/08\/09",
    "發證日期": "91\/08\/09",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202351208",
    "中文品名": "宜克喘吸入液２５０微克／公撮",
    "英文品名": "IPRATROPIUM BROMIDE INHALATION SOLUTION 250MCG\/ML",
    "適應症": "慢性阻塞性支氣管炎、支氣管氣喘。",
    "劑型": "479吸入用液劑",
    "包裝": "1 公撮塑膠安瓿裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "IPRATROPIUM BROMIDE",
    "限制項目": "02輸　入 1Q不得輸入",
    "申請商名稱": "1504401100  輝瑞大藥廠股份有限公司",
    "申請商地址": "台北市信義區松仁路100號42、43樓",
    "主製造廠": [
        {
            "製造廠名稱": "FAU0034000  PFIZER (PERTH) PTY LIMITED",
            "製造廠廠址": "15 BRODIE HALL DRIVE, TECHNOLOGY PARK, BENTLEY WESTERN 6102 AUSTRALIA",
            "製造廠公司地址": "",
            "製造廠國別": "AUSTRALIA",
            "製程": ""
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1208002710",
            "成分名稱": "IPRATROPIUM BROMIDE",
            "含量描述": "",
            "含量": "250.0000000000",
            "單位": "MCG"
        }
    ]
}